THIS MESSAGE (MATERIAL) IS CREATED AND (OR) DISTRIBUTED BY A FOREIGN MASS MEDIA PERFORMING THE FUNCTIONS OF A FOREIGN AGENT AND (OR) A RUSSIAN LEGAL ENTITY PERFORMING THE FUNCTIONS OF A FOREIGN AGENT.
The Federal Service for Surveillance in Healthcare (Roszdravnadzor) has decided to switch to the daily collection of data on the availability of vaccines and drugs against coronavirus infection COVID-19 using the drug labeling system.
Thus, the Kommersant newspaper reports today, the Russian government hopes to prevent a possible shortage of medical supplies due to the spread of a new strain of the omicron coronavirus throughout the country.
According to the estimates of the operational headquarters for the fight against COVID-19, more than 100 thousand Russians become infected with it every day.
Recall that last week the Vedomosti newspaper indicated, with reference to a study by the All-Russian Popular Front (ONF), that almost a third of those who had COVID-19 in Russia did not receive free medicines in January.
Meanwhile, it became known earlier that the Gamaleya Center introduced new side effects into the instructions for the Sputnik V coronavirus vaccine. As the Pharmaceutical Bulletin noted, the “side effects” were osteoarthritis and photophobia.
Source: Rosbalt
Tristin is an accomplished author and journalist, known for his in-depth and engaging writing on sports. He currently works as a writer at 247 News Agency, where he has established himself as a respected voice in the sports industry.
